Lakefront Biotherapeutics NV (GLPG) Q2 2025 Earnings

Apr 23Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-2.54
-1.6
-0.65
0.3

Details

Expected EPS
-0.14696824065
Actual EPS
-2.5423475
Surprise EPS
-2.4
Surprise Percent
-1,629.86%

Description

⁨Lakefront Biotherapeutics NV⁩ (⁦GLPG⁩) has reported earnings of ⁦-2.5423475⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts